Bioclinic
FranceEntry
2012
Hold
6yr
Exit
2018
Who owns Bioclinic?
Bioclinic was owned by Azulis Capital through Azulis MMF IV (2011 vintage) from 2012 to 2018, exited via Secondary. Across its history, Bioclinic has been through 2 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Most recent investor
Azulis CapitalAzulis MMF IV · 2011 · Buyout
3 ownership periods · full history below
Key facts
HQFrance
SectorHealthcare
Key takeaways
- ·Fully exited in 2018.
- ·Average hold across 2 realized cycles: 6 years.
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Exited
Last exited in 2018 to .
Co-invest · 2 holders · 2012 · 2018
Andera PartnersLender · repaid 2022
2018 · 2022(4yr) · Acto Mezzanine III · 2017 · Mezzanine
Trade Sale · to
MOIC
–
More from Azulis MMF IV
Other portfolio companies in the same fund.
More PE-backed in Healthcare
Comparable healthcare deals from other GPs.
US
Track Bioclinic
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Bioclinic?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Bioclinic.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue